Darrell Rigel - STRATA Skin Chief Advisor
| SSKN Stock | USD 3.15 0.12 3.96% |
Insider
Darrell Rigel is Chief Advisor of STRATA Skin Sciences
| Age | 73 |
| Address | 5 Walnut Grove Drive, Horsham, PA, United States, 19044 |
| Phone | 215 619 3200 |
| Web | https://www.strataskinsciences.com |
STRATA Skin Management Efficiency
The company has return on total asset (ROA) of (0.0679) % which means that it has lost $0.0679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6297) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.3. At this time, STRATA Skin's Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | INSIDER Age | ||
| John Rondoni | Inspire Medical Systems | 44 | |
| Mary Moreland | Abbott Laboratories | 58 | |
| Michael Pederson | Abbott Laboratories | 59 | |
| Lauren Budden | Insulet | 49 | |
| Louis Morrone | Abbott Laboratories | 44 | |
| Michael Kreindel | InMode | 56 | |
| Alejandro Wellisch | Abbott Laboratories | 49 | |
| Moshe Mizrahy | InMode | 71 | |
| Michael Dale | Abbott Laboratories | 61 | |
| Elaine Leavenworth | Abbott Laboratories | 65 | |
| Yair Malca | InMode | 46 | |
| James Young | Abbott Laboratories | N/A | |
| Randel Woodgrift | Abbott Laboratories | 59 | |
| Christopher Calamari | Abbott Laboratories | 50 | |
| Gregory Ahlberg | Abbott Laboratories | 54 | |
| Philip Boudreau | Abbott Laboratories | 51 | |
| Ross Sylvia | Tandem Diabetes Care | N/A | |
| Arani MD | Penumbra | 62 | |
| Georgia Melenikiotou | Inspire Medical Systems | 61 | |
| Michael Roman | Abbott Laboratories | 61 | |
| Rick Carpenter | Tandem Diabetes Care | 61 | |
Management Performance
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.0679 |
STRATA Skin Sciences Leadership Team
Elected by the shareholders, the STRATA Skin's board of directors comprises two types of representatives: STRATA Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRATA. The board's role is to monitor STRATA Skin's management team and ensure that shareholders' interests are well served. STRATA Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRATA Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dolev Rafaeli, CEO President | ||
| Shmuel Gov, Chief Officer | ||
| John Gillings, VP Finance | ||
| Robert Moccia, CEO Pres | ||
| William MBA, Ex Chairman | ||
| Michael Stewart, CEO and President and Director | ||
| Michael Goodman, Head Sales | ||
| Darrell Rigel, Chief Advisor | ||
| Keith Simeone, VP Sales | ||
| Nikolai Kabelev, VP RD | ||
| Christopher Lesovitz, Chief Officer | ||
| Jay Sturm, General Secretary |
STRATA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRATA Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.0679 | ||||
| Profit Margin | (0.25) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 22.55 M | ||||
| Shares Outstanding | 4.17 M | ||||
| Shares Owned By Insiders | 2.91 % | ||||
| Shares Owned By Institutions | 60.39 % | ||||
| Number Of Shares Shorted | 7 K | ||||
| Price To Earning | (0.49) X |
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving against STRATA Stock
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.